Preregistration
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: A Systematic Review of Open-Label Studies and Randomized Trials
Abstract
This systematic review aims to examine open-label studies and randomized trials investigating 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for post-traumatic stress disorder (PTSD), with an emphasis on clinical outcomes. This includes safety, tolerability, efficacy, and durability. Pharmacological and psychotherapeutic regimens, as well as assessment measures, will additionally be explored.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticleMDMA
Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.
ArticlePsilocybin
Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.
PreprintMDMA